ALL ARTICLES AND PRODUCT INFORMATION PROVIDED ON THIS WEBSITE ARE FOR INFORMATIONAL AND EDUCATIONAL PURPOSES ONLY. The products offered on this website are intended solely for research and laboratory use. These products are not intended for human or animal consumption. They are not medicines or drugs and have not been evaluated or approved by the FDA to diagnose, treat, cure, or prevent any disease or medical condition. Any form of bodily introduction is strictly prohibited by law.
SS-31 (elamipretide) targets cardiolipin-associated mitochondrial function. Clinical outcomes have varied by indication, with regulatory progress in Barth syndrome.
SS-31 (elamipretide) is a mitochondria-targeted tetrapeptide investigated for cardiolipin-associated bioenergetic stabilization across multiple indications.
Add this item to your cart, submit your shipping details at checkout, and wait for your order confirmation. Interac e-Transfer instructions are sent after the order request is received.
| Catalog category | Mitochondrial & Cellular‑Energy Peptides |
|---|---|
| Source category | Mitochondrial Peptides |
| Composition | SS-31 / Elamipretide |
| Research status | approved |
| Regulatory | Recent literature and federal records indicate U.S. accelerated approval in Barth syndrome (September 19, 2025). |
| Research note | Status statements are indication-specific and should always be validated against current regulatory sources. |
| Keywords | 10mg, 31, antioxidant, cellular, endurance, energy, longevity, metabolism, mitochondrial, peptide, peptides, ss |
Consider these supplementary peptides for a comprehensive research approach.
Our team is ready to assist you with any inquiries regarding our catalogue of peptides and their applications.
Discount Applied Successfully!
Your savings have been added to the cart.
